Eric Rosiek

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Eric Rosiek

Oct 23, 2024, 12:33 | Insight

Sarat Chandarlapaty: HER2 ADCs and the role of EGFR in oncology

Sarat Chandarlapaty shared the following post on LinkedIn: “HER2 ADCs continue to re-shape solid tumor…

Jul 26, 2024, 00:16 | Insight

Impact of the intratumoral microbiome of NSCLC on outcomes with immunotherapy

Stephen Liu shared on X: "Impressive work on impact of the intratumoral microbiome of NSCLC…

Jul 25, 2024, 00:32 | Blog

Jarushka Naidoo: Can intratumor eschericia improve OS from ICIs in NSCLC

Jarushka Naidoo shared a post on X: ''Can intratumor eschericia (E) bring immune cells to…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023